NCT01254617
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +66 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Clinical trial condition
Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma
Explore clinical trials studying Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma. Study availability and eligibility vary by location and protocol.
4 public trials
0 recruiting studies
Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma trial results
NCT01256385
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
NCT00458978
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +36 more
- Locations
-
- Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
Active, Not Recruiting
Vorinostat and Azacitidine in Treating Patients With Locally Recurrent or Metastatic Nasopharyngeal Cancer or Nasal Natural Killer T-Cell Lymphoma
NCT00336063
- Conditions
- Adult Nasal Type Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +8 more
- Locations
-
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
- Chinese University of Hong Kong-Prince of Wales Hospital Shatin, Hong Kong
- National Cancer Center Hospital Tokyo, Japan
- National University Hospital Singapore Singapore